Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes

Hideki Izumi, Chiaki Takahashi, Jun Seo Oh, Makoto Noda

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

A human placenta cDNA expression library was screened for genes inducing flat reversion when transfected into a v-K-ras-transformed NIH3T3 cell line, DT. One such gene was found to encode a Kunitz-type serine protease inhibitor, tissue factor pathway inhibitor-2 (TFPI-2). While the TFPI-2 mRNA can be detected in normal human fibroblasts (MRC-5), it is down-regulated in MRC-5 cells expressing an activated H-ras oncogene and in the human fibrosarcoma cell line, HT1080. Restored expression of the TFPI-2 gene in HT1080 cells resulted in the suppression of matrix invasion activity in vitro with concomitant decrease in the relative amount of active matrix metalloproteinase-2 secreted from the cells. When DT cells were cultured in the presence of conditioned medium and extracellular matrix prepared from TFPI-2-transfected HT1080 cells, increased attachment and flat reversion were observed. These results suggest that TFPI-2 may be required for the maintenance of the integrity of extracellular matrix in normal tissues and its down-regulation as a result of oncogene activation may contribute to the malignant phenotypes of tumor cells. Copyright (C) 2000 Federation of European Biochemical Societies.

Original languageEnglish
Pages (from-to)31-36
Number of pages6
JournalFEBS Letters
Volume481
Issue number1
DOIs
Publication statusPublished - 2000 Sep 8
Externally publishedYes

Fingerprint

ras Genes
Matrix Metalloproteinase 2
Cells
Genes
Extracellular Matrix
Transformed Cell Line
Serine Proteinase Inhibitors
Fibrosarcoma
Fibroblasts
Conditioned Culture Medium
Gene Library
Oncogenes
Placenta
Tumors
Cultured Cells
Down-Regulation
Complementary DNA
Chemical activation
Maintenance
tissue-factor-pathway inhibitor 2

Keywords

  • Matrix metalloproteinase-2
  • ras oncogene
  • Tissue factor pathway inhibitor-2
  • Transformation suppressor gene
  • Tumor invasion

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes. / Izumi, Hideki; Takahashi, Chiaki; Oh, Jun Seo; Noda, Makoto.

In: FEBS Letters, Vol. 481, No. 1, 08.09.2000, p. 31-36.

Research output: Contribution to journalArticle

@article{00cc21234c864c48ac0920b1f3b213b0,
title = "Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes",
abstract = "A human placenta cDNA expression library was screened for genes inducing flat reversion when transfected into a v-K-ras-transformed NIH3T3 cell line, DT. One such gene was found to encode a Kunitz-type serine protease inhibitor, tissue factor pathway inhibitor-2 (TFPI-2). While the TFPI-2 mRNA can be detected in normal human fibroblasts (MRC-5), it is down-regulated in MRC-5 cells expressing an activated H-ras oncogene and in the human fibrosarcoma cell line, HT1080. Restored expression of the TFPI-2 gene in HT1080 cells resulted in the suppression of matrix invasion activity in vitro with concomitant decrease in the relative amount of active matrix metalloproteinase-2 secreted from the cells. When DT cells were cultured in the presence of conditioned medium and extracellular matrix prepared from TFPI-2-transfected HT1080 cells, increased attachment and flat reversion were observed. These results suggest that TFPI-2 may be required for the maintenance of the integrity of extracellular matrix in normal tissues and its down-regulation as a result of oncogene activation may contribute to the malignant phenotypes of tumor cells. Copyright (C) 2000 Federation of European Biochemical Societies.",
keywords = "Matrix metalloproteinase-2, ras oncogene, Tissue factor pathway inhibitor-2, Transformation suppressor gene, Tumor invasion",
author = "Hideki Izumi and Chiaki Takahashi and Oh, {Jun Seo} and Makoto Noda",
year = "2000",
month = "9",
day = "8",
doi = "10.1016/S0014-5793(00)01902-5",
language = "English",
volume = "481",
pages = "31--36",
journal = "FEBS Letters",
issn = "0014-5793",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes

AU - Izumi, Hideki

AU - Takahashi, Chiaki

AU - Oh, Jun Seo

AU - Noda, Makoto

PY - 2000/9/8

Y1 - 2000/9/8

N2 - A human placenta cDNA expression library was screened for genes inducing flat reversion when transfected into a v-K-ras-transformed NIH3T3 cell line, DT. One such gene was found to encode a Kunitz-type serine protease inhibitor, tissue factor pathway inhibitor-2 (TFPI-2). While the TFPI-2 mRNA can be detected in normal human fibroblasts (MRC-5), it is down-regulated in MRC-5 cells expressing an activated H-ras oncogene and in the human fibrosarcoma cell line, HT1080. Restored expression of the TFPI-2 gene in HT1080 cells resulted in the suppression of matrix invasion activity in vitro with concomitant decrease in the relative amount of active matrix metalloproteinase-2 secreted from the cells. When DT cells were cultured in the presence of conditioned medium and extracellular matrix prepared from TFPI-2-transfected HT1080 cells, increased attachment and flat reversion were observed. These results suggest that TFPI-2 may be required for the maintenance of the integrity of extracellular matrix in normal tissues and its down-regulation as a result of oncogene activation may contribute to the malignant phenotypes of tumor cells. Copyright (C) 2000 Federation of European Biochemical Societies.

AB - A human placenta cDNA expression library was screened for genes inducing flat reversion when transfected into a v-K-ras-transformed NIH3T3 cell line, DT. One such gene was found to encode a Kunitz-type serine protease inhibitor, tissue factor pathway inhibitor-2 (TFPI-2). While the TFPI-2 mRNA can be detected in normal human fibroblasts (MRC-5), it is down-regulated in MRC-5 cells expressing an activated H-ras oncogene and in the human fibrosarcoma cell line, HT1080. Restored expression of the TFPI-2 gene in HT1080 cells resulted in the suppression of matrix invasion activity in vitro with concomitant decrease in the relative amount of active matrix metalloproteinase-2 secreted from the cells. When DT cells were cultured in the presence of conditioned medium and extracellular matrix prepared from TFPI-2-transfected HT1080 cells, increased attachment and flat reversion were observed. These results suggest that TFPI-2 may be required for the maintenance of the integrity of extracellular matrix in normal tissues and its down-regulation as a result of oncogene activation may contribute to the malignant phenotypes of tumor cells. Copyright (C) 2000 Federation of European Biochemical Societies.

KW - Matrix metalloproteinase-2

KW - ras oncogene

KW - Tissue factor pathway inhibitor-2

KW - Transformation suppressor gene

KW - Tumor invasion

UR - http://www.scopus.com/inward/record.url?scp=0034623346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034623346&partnerID=8YFLogxK

U2 - 10.1016/S0014-5793(00)01902-5

DO - 10.1016/S0014-5793(00)01902-5

M3 - Article

C2 - 10984610

AN - SCOPUS:0034623346

VL - 481

SP - 31

EP - 36

JO - FEBS Letters

JF - FEBS Letters

SN - 0014-5793

IS - 1

ER -